These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19207502)

  • 21. Cardiovascular Disease, Atherosclerosis and Familial Hypercholesterolemia: From Molecular Mechanisms Causing Pathogenicity to New Therapeutic Approaches.
    Jebari-Benslaiman S; Larrea-Sebal A; Benito-Vicente A; Martín C
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Combined familial hypercholesterolemia and type III hyperlipoproteinemia].
    Levy Y; Aviram M; Baruch Y; Brook JG
    Harefuah; 1984 Jun; 106(12):565-6. PubMed ID: 6479724
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardiovascular disease in familial hypercholesterolaemia: influence of low-density lipoprotein receptor mutation type and classic risk factors.
    Alonso R; Mata N; Castillo S; Fuentes F; Saenz P; Muñiz O; Galiana J; Figueras R; Diaz JL; Gomez-Enterría P; Mauri M; Piedecausa M; Irigoyen L; Aguado R; Mata P;
    Atherosclerosis; 2008 Oct; 200(2):315-21. PubMed ID: 18243212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Risk of breast cancer and other diseases--how strongly should it be emphasized?].
    Jacobsen BK; Schirmer H
    Tidsskr Nor Laegeforen; 1999 Oct; 119(24):3625-7. PubMed ID: 10563183
    [No Abstract]   [Full Text] [Related]  

  • 25. Cellular senescence, telomeres, and cardiovascular risk in familial hypercholesterolaemia.
    Banach M; Penson PE
    Eur J Prev Cardiol; 2022 May; 29(5):718-720. PubMed ID: 33624078
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of atorvastatin in achieving National Cholesterol Education Program low-density lipoprotein targets in women with severe dyslipidemia and cardiovascular disease or risk factors for cardiovascular disease: The Women's Atorvastatin Trial on Cholesterol (WATCH).
    McPherson R; Angus C; Murray P; Genest J;
    Am Heart J; 2001 Jun; 141(6):949-56. PubMed ID: 11376309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What homozygous familial hypercholesterolemia produces and the will to withstand its complications.
    Zamirian M
    Am J Cardiol; 2011 Dec; 108(12):1840-1. PubMed ID: 22133134
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cholesterol--now what?].
    Smith P
    Tidsskr Nor Laegeforen; 2001 Mar; 121(9):1022. PubMed ID: 11354872
    [No Abstract]   [Full Text] [Related]  

  • 29. [Homozygous familial hypercholesterolemia. Cardiovascular findings in two patients (author's transl)].
    Keller C; Lohmöller G; Schmitz H
    MMW Munch Med Wochenschr; 1980 Nov; 122(48):1717-20. PubMed ID: 6779135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New treatments on the horizon for familial hypercholesterolemia.
    Allian-Sauer MU; Falko JM
    Expert Rev Cardiovasc Ther; 2012 Oct; 10(10):1227-37. PubMed ID: 23190063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defining the challenges of FH screening for familial hypercholesterolemia.
    Defesche JC
    J Clin Lipidol; 2010; 4(5):338-41. PubMed ID: 21122674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Familial hypercholesterolemia].
    Windler E; Beil FU; Altenburg C; Rinninger F
    Dtsch Med Wochenschr; 2012 Nov; 137(46):2375-9. PubMed ID: 23132157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation.
    Alonso R; Andres E; Mata N; Fuentes-Jiménez F; Badimón L; López-Miranda J; Padró T; Muñiz O; Díaz-Díaz JL; Mauri M; Ordovás JM; Mata P;
    J Am Coll Cardiol; 2014 May; 63(19):1982-9. PubMed ID: 24632281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevent cardiovascular disease in women.
    Holcomb SS
    Nurse Pract; 2004 Jul; 29(7):6-11. PubMed ID: 15238852
    [No Abstract]   [Full Text] [Related]  

  • 35. Hypercholesterolemia and atherosclerosis in the WHHL rabbit, an animal model of familial hypercholesterolemia.
    Shiomi M; Ito T; Watanabe Y
    Prog Clin Biol Res; 1987; 229():35-40. PubMed ID: 3601993
    [No Abstract]   [Full Text] [Related]  

  • 36. Altered hemostatic balance and endothelial activation in pregnant women with familial hypercholesterolemia.
    Amundsen AL; Khoury J; Sandset PM; Seljeflot I; Ose L; Tonstad S; Henriksen T; Retterstøl K; Iversen PO
    Thromb Res; 2007; 120(1):21-7. PubMed ID: 16914186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients.
    Jansen AC; van Aalst-Cohen ES; Tanck MW; Trip MD; Lansberg PJ; Liem AH; van Lennep HW; Sijbrands EJ; Kastelein JJ
    J Intern Med; 2004 Dec; 256(6):482-90. PubMed ID: 15554949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homozygous familial hypercholesterolemia.
    Diwan AG; Krishna KK; Jain MM; Arafat M; Sardesai VR; Dube MN
    J Assoc Physicians India; 2002 May; 50(5):738-9. PubMed ID: 12186142
    [No Abstract]   [Full Text] [Related]  

  • 39. Familial hypercholesterolemia: mechanism of inheritance.
    de Oya M; Nuno J; Azpeitia AG; Villasante JG
    Diabete Metab; 1980 Sep; 6(3):181-8. PubMed ID: 7439491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular calcification in homozygote familial hypercholesterolemia.
    Morrisett JD; Vickers KC
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):606-7. PubMed ID: 18354092
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.